WuXi Biologics (Cayman) Inc.
General ticker "WXIBF" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.2B (TTM average)
WuXi Biologics (Cayman) Inc. follows the US Stock Market performance with the rate: 37.9%.
Estimated limits based on current volatility of 2.7%: low 4.63$, high 4.88$
Short-term WXIBF quotes
Long-term WXIBF plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | CNY15,268.66MM | CNY17,034.26MM | CNY18,675.37MM |
| Operating Expenses | CNY10,926.74MM | CNY12,584.06MM | CNY13,701.57MM |
| Operating Income | CNY4,341.92MM | CNY4,450.20MM | CNY4,973.80MM |
| Non-Operating Income | CNY1,015.85MM | CNY-276.39MM | CNY-139.41MM |
| Interest Expense | CNY64.38MM | CNY158.49MM | CNY157.59MM |
| R&D Expense | CNY682.82MM | CNY792.58MM | CNY766.44MM |
| Income(Loss) | CNY5,357.77MM | CNY4,173.80MM | CNY4,834.40MM |
| Taxes | CNY807.87MM | CNY603.18MM | CNY889.03MM |
| Profit(Loss)* | CNY4,420.29MM | CNY3,399.73MM | CNY3,356.08MM |
| Stockholders Equity | CNY35,047.41MM | CNY40,331.60MM | CNY41,819.21MM |
| Inventory | CNY2,280.91MM | CNY1,765.75MM | CNY1,521.67MM |
| Assets | CNY49,564.39MM | CNY56,575.73MM | CNY56,977.43MM |
| Operating Cash Flow | CNY5,541.67MM | CNY4,667.71MM | CNY5,217.26MM |
| Capital expenditure | CNY5,868.39MM | CNY4,230.51MM | CNY3,929.62MM |
| Investing Cash Flow | CNY-5,908.25MM | CNY-3,228.27MM | CNY-3,941.71MM |
| Financing Cash Flow | CNY-2,591.59MM | CNY1,961.16MM | CNY-2,750.19MM |
| Earnings Per Share** | CNY1.06 | CNY0.82 | CNY0.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.